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The 14-3-3 family of proteins are multifunctional proteins
that interact with many of their cellular targets in a phosphory-
lation-dependent manner. Here, we determined that 14-3-3
proteins interact with phosphorylated forms of the water
channel aquaporin-2 (AQP2) and modulate its function. With
the exception of , all 14-3-3 isoforms were abundantly
expressed in mouse kidney and mouse kidney collecting duct
cells (mpkCCD14). Long-term treatment of mpkCCD14 cells
with the type 2 vasopressin receptor agonist dDAVP increased
mRNA and protein levels of AQP2 alongside 14-3-3 and -,
whereas levels of 14-3-3 and - were decreased. Co-immuno-
precipitation (co-IP) studies in mpkCCD14 cells uncovered an
AQP2/14-3-3 interaction that was modulated by acute dDAVP
treatment. Additional co-IP studies in HEK293 cells deter-
mined that AQP2 interacts selectively with 14-3-3 and -. Use
of phosphatase inhibitors in mpkCCD14 cells, co-IP with phos-
phorylationdeficient formsofAQP2expressed inHEK293 cells,
or surface plasmon resonance studies determined that the
AQP2/14-3-3 interaction was modulated by phosphorylation
of AQP2 at various sites in its carboxyl terminus, with Ser-256
phosphorylation critical for the interactions. shRNA-mediated
knockdown of 14-3-3 in mpkCCD14 cells resulted in increased
AQP2 ubiquitylation, decreased AQP2 protein half-life, and
reduced AQP2 levels. In contrast, knockdown of 14-3-3
resulted in increased AQP2 half-life and increased AQP2 levels.
In conclusion, this study demonstrates phosphorylation-depen-
dent interactions of AQP2 with 14-3-3 and -. These interac-
tionsplaydivergent roles inmodulatingAQP2 trafficking, phos-
phorylation, ubiquitylation, and degradation.
The 14-3-3 family are highly conserved proteins expressed in
eukaryotic cells that play well established roles in interacting
and modulating the function of target proteins at numerous
levels (1–3). Seven 14-3-3 isoforms have been identified in
mammalian cells (encoded by 7 different genes): , , , , , ,
and . Each are functional as homo- or heterodimers, displaying
high affinity binding via selective interaction motifs in their
target proteins (1–3). Although 14-3-3 protein interactions are
often dependent on the phosphorylation status of their target
protein, with binding motifs commonly containing phosphor-
ylated serine or threonine residues (1, 4, 5), bindingmotifs con-
taining non-phosphorylated residues have also been identified
(6). Once docked, 14-3-3 dimers have been proposed to regu-
late the function of their target proteins in various manners,
including: 1) acting as an “adaptor” for modulating interaction
between two target proteins that each bind to a 14-3-3 mono-
mer; 2) mediating conformational changes to modulate target
protein activity; and 3) competing with other interaction pro-
teins to control post-translationalmodification and/or localiza-
tion of the target protein (1, 7). Due to essential roles of 14-3-3
proteins in modulating signal transduction pathways and pro-
tein trafficking (2, 8), dysfunction of 14-3-3 proteins are linked
to diseases including cancer (8, 9), metabolic disorders, and
altered cell proliferation (10).
In the kidney, 14-3-3 proteins are expressed throughout the
renal tubule (e.g. Refs. 11–13), including the principal cells of
the kidney collecting duct (14). The primary functions of these
cells are to regulate NaCl (via the epithelial sodium channel,
ENaC)2 and water (via the water channel aquaporin-2, AQP2)
transport from the preurine back to the blood and help main-
tain bodyNaCl andwater homeostasis. A role of 14-3-3 tomod-
ulate ENaC function andNaCl transport is well established (e.g.
Refs. 15–18). The 14-3-3 isoforms  and  constitutes a het-
erodimer that interacts with a phosphorylated form of the E3
ligase Nedd4-2, blocking the interaction of Nedd4-2 with
ENaC, reducing ENaC ubiquitylation and thereby increasing
apical ENaC density and sodium transport. Furthermore, the
steroid hormone aldosterone, which increases ENaC function,
also increases abundance of 14-3-3 and -; suggesting that
14-3-3 isoform abundance can be selectively modulated by var-
ious hormones. In respect to water transport, although 14-3-3
and - are associated with intracellular AQP2 vesicles in the
inner medullary collecting duct (19), a role for 14-3-3 proteins
in modulating AQP2 function is not established. AQP2 func-
tions as a tetrameric protein with the carboxyl termini located* This work was supported by the Danish Medical Research Council, the Lun-
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tion, MEMBRANES, and the Aarhus University Research Foundation. The
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inside the cell (20). This tail domain is highly phosphorylated,
with the levels of phosphorylation at Ser-256, Ser-261, Ser-264,
and Ser-269 (Thr in human) residues being modulated by the
hormone arginine vasopressin (AVP) (21, 22), acting via the
vasopressin type 2 receptor (V2R). These phosphorylation sites
play alternative roles in the subcellular distribution and func-
tion of AQP2, e.g. the apical plasmamembrane accumulation of
AQP2 in response to AVP treatment is modulated by Ser-256
and Ser-269 phosphorylation (23–28). Although the underlying
mechanisms for AQP2 regulation via phosphorylation are not
completely clear, phosphorylation-dependent protein interac-
tions appear to play a crucial role (29). In addition, the carboxyl-
terminal tail of AQP2 is furthermodified by ubiquitylation (30).
A complex interplay betweenAQP2 phosphorylation and ubiq-
uitylation is responsible for modulating the abundance of
AQP2 on the plasma membrane (23).
In this study, we tested the hypothesis that AQP2 function is
regulated by interaction with 14-3-3 proteins and that these
interactions are modulated by AVP. In mouse kidney and a
collecting duct cell line (mpkCCD14), 14-3-3 isoforms were
identified at the mRNA and protein levels, several of which
were modified in abundance by AVP. These 14-3-3 isoforms
had alternative subcellular distributions in mouse kidney col-
lecting duct cells. Biochemical studies identified an AVP-regu-
lated and phosphorylation-dependent interaction between
AQP2 and 14-3-3 and -. Knockdown of  and  inmpkCCD14
cells indicated that  reduces AQP2 trafficking to the plasma
membrane, whereas  prevents AQP2 ubiquitylation and deg-
radation. Our data provide additional evidence that AQP2
function is highly dependent on phosphorylation-dependent
protein interactions with its carboxyl-terminal domain.
Experimental Procedures
Antibodies and Chemicals—Affinity-purified rabbit phos-
pho-specific antibodies against Ser(P)-269-AQP2 or against
total AQP2 upstream of known phosphorylation sites have pre-
viously been characterized (21, 24). Rabbit anti-V2R has been
characterized previously (31). Mouse anti-ubiquitin (P4D1)
was from Cell Signaling. Total 14-3-3 antibodies (catalog num-
bers sc629 and sc1657) were from Santa Cruz. 14-3-3 isoform-
specific antibodies  (number 9636),  (number 9635),  (num-
ber D15B7),  (number D23B7),  (number 9638), and 
(number 7413) were fromCell Signaling. Anti-HA tag (H3663),
GST (numberG1160), and	-tubulin (T6074)were fromSigma.
The phosphatase inhibitors okadaic acid (OA) and calyculin A
(CA) were from Calbiochem. Forskolin (Sigma) was used at a
final concentration of 25 
M.
Tissue Isolation from Mice—All animal protocols comply
with the European Community guidelines for the use of exper-
imental animals and were performed in accordance to licenses
for the use of experimental animals issued by the Danish Min-
istry of Justice. Mice were euthanized by cervical dislocation,
kidneys were removed and dissected into cortex and inner
medulla regions. Tissue was either processed for RNA extrac-
tion (see below) or homogenized in ice-cold isolation solution
(250 mM sucrose, 10 mM triethanolamine, pH 7.6, containing
the protease inhibitors leupeptin (1mg/ml) and Pefa-block (0.1
mg/ml) (Roche Applied Science) and phosphatase inhibitor
mixture tablets (PhosSTOP, Roche Diagnostics A/S)) for gen-
eration of SDS-PAGE gel samples.
Immunohistochemical Labeling of Mouse Kidney and Confo-
cal Imaging—Kidneys were perfused with 4% paraformalde-
hyde in PBS via the heart and post-fixed for 60 min in the same
buffer. Tissuewas immersed in 20% sucrose in PBS at 4 °C over-
night and rapidly frozen using liquid nitrogen. 10-
m sections
were cut, placed on Superfrost Plus slides, and heated to 60 °C
for 10 min. After 30 min incubation in 50 mM NH4Cl in PBS to
quench aldehydes, sections were dehydrated and rehydrated
through a series of alcohol (70, 96, 99, 96, and 70%). The fluo-
rescent labeling procedure was performed as previously
described (24). Coverslips were mounted with a hydrophilic
mounting medium containing anti-fading reagent (DAKO,
glycergel). A Leica TCS SL confocal microscope with an HCX
PL APO 63 oil objective lens (numerical aperture: 1.40) was
used for obtaining images.
mpkCCD14 Cell Culture and Experimental Conditions—
mpkCCD14 cells were cultured as described (32) on semi-per-
meable supports (0.4 
M pore size, Corning) until a confluent
monolayer formed and TER was above 5 kOhm/cm2. Where
indicated, the AVP type II receptor selective agonist [deamino-
Cys1,D-Arg8]vasopressin (dDAVP) (109 M, Sigma) was added
in serum-free media to the basolateral compartment for 24–96
h to induce AQP2 expression. For experiments requiring acute
dDAVP stimulation, cells were washed twice in puremedia and
reincubated in pure media for 3 h before re-stimulated with
dDAVP (109 M) from the basolateral side for 20 min at 37 °C.
In dDAVP washout experiments, cells were subsequently
washed twice in puremedia and reincubated for 30min at 37 °C
before sample preparation. In phosphatase inhibitor experi-
ments, where indicated OA (200 nM) and CA (100 nM) were
included during the washout period. For cycloheximide chase
studies, cells were grown in dDAVP for 4 days on semi-perme-
able supports, following which cells were incubated for various
time points at 37 °C and 5% CO2 in 50 
M cycloheximide (in
dimethyl sulfoxide). Cells were washed twice in PBS and pro-
teins were extracted in Laemmli sample buffer containing 10
mg/ml of DTT. For calculation of the protein half-life, average
band densities for each time point were normalized to control
and fitted using nonlinear regression and a one-phase exponen-
tial decay equation using GraphPad Prism software. Data were
obtained from four independent experiments, with 3–6 obser-
vations for each individual time point.
Transduction of 14-3-3 Lentivirus—MISSION lentiviral
transduction particles against 14-3-3 (numbers 76393, 76394,
312369, 312371, and 349888) and - (numbers 71053, 71054,
71056, 71057, and 316456) and corresponding control particles
(SHC002) were from Sigma. mpkCCD14 cells were cultured as
described (32) in 6-well plates until 95% confluent. Cells were
treatedwith hexadimethrine bromide (8
g/ml final concentra-
tion) for 15 min in pure media, before addition of lentiviral
particles (multiplicity of infection  4). Transduction was
allowed to proceed for 24 h, after which media was switched to
mpkCCD14 media containing 2 
g/ml of puromycin for selec-
tion. Multiple clonal cell lines were isolated and individually
characterized by examination of cell morphology, high TER
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when grown on semi-permeable supports, and 14-3-3 expres-
sion levels by Western blotting and qRT-PCR.
Surface Biotinylation of mpkCCD14 Cells—Apical plasma
membrane proteins were labeled with EZ-link hydrazide-bio-
cytin (Pierce), which reacts with oxidized glycans of glycosy-
lated proteins, using a modified published protocol (33, 34).
Following various experimental manipulations, cells were
washed in ice-cold coupling buffer (sodium phosphate, 0.1 M;
NaCl, 0.15 M, pH 7.2) and incubated with sodium metaperio-
date (20 mM) in coupling buffer for 30 min on ice in the dark.
After washes in coupling buffer, cells were incubated from the
apical side using 2.5 mM hydrazide-biocytin for 30 min on ice.
Subsequently, cells were incubated with quenching solution
(NH4Cl, 50 mM, in PBS, pH 7.4) for 5 min and washed in cou-
pling buffer. Cells were lysed in a buffer containing: 50 mM
Tris, pH 7.5, 140 mMNaCl, 5 mM CaCl2, 5 mMMgCl2, 1% Non-
idet P-40 supplemented with EDTA-free Halt Protease and
Phosphatase Inhibitor Mixture (Invitrogen). Samples were
purified as described previously (29), with labeled proteins
eluted by incubation in Laemmli sample buffer containing 10
mg/ml of DTT for 10 min at 95 °C.
Immunoprecipitation (IP) Using mpkCCD14 Cells—Immu-
noprecipitation was performed as previously described (23).
HEK Cell Culture, Transfection, and Immunoprecipitation—
HEK293 cells (ATCCCRL-1573) were cultured at 37 °C and 5%
CO2 in Dulbecco’s modified Eagle’s medium/GlutaMAX
(Invitrogen) supplemented with 10% donor bovine serum, 100
IU/ml each of penicillin and streptomycin in 6-well plates until
95% confluent. Cells were transfected with AQP2 (21) and var-
ious HA-tagged 14-3-3 constructs (16) using Lipofectamine
2000 reagent (Invitrogen) following standard procedures. After
36 h, cells were washed in ice-cold PBS-CM, pH 8.0 (PBS con-
taining 1 mM CaCl2 and 0.1 mM MgCl2), and incubated with
forskolin (1 
M final) for 15 min before addition of lysis buffer
(50 mM Tris, pH 7.5, 140 mM NaCl, 5 mM CaCl2, 5 mM MgCl2,
1% Nonidet P-40) containing EDTA-free Halt Protease and
Phosphatase Inhibitor Mixture (Invitrogen). Immunoprecipi-
tations were performed for 2 h at room temperature on equal
protein quantities of cleared lysates using Protein A/G Dyna-
beads (Invitrogen). Extensive washes were performed using
lysis buffer and captured proteins were eluted using Laemmli
sample buffer containing 10 mg/ml of DTT. All immunopre-
cipitation assays were repeated twice with different batches of
transfected cells, but yielded similar results.
Specificity of 14-3-3 Isoform Selective Antibodies—HEK293
cells were transfected with various HA-tagged 14-3-3 con-
structs (16) using Lipofectamine 2000 reagent (Invitrogen) fol-
lowing standard procedures. After 36 h cells were washed twice
in PBS and proteins were extracted in Laemmli sample buffer
containing 10 mg/ml of DTT before blotting with various iso-
form-selective antibodies.
GST Pulldown Assay—mpkCCD14 cells were treated with
dDAVP for 30 min and lysates were prepared as described
under “HEK Cell Immunoprecipitations,” as described above.
Lysates were pre-cleared by incubation with 100 
l of glutathi-
one-agarose (Thermo Scientific) for 120 min at 4 °C. GST-14-
3-3 fusion constructs (Sino Biological Inc.) were purified using
Zeba spin columns (Thermo Scientific) to remove excess glu-
tathione. 30 
g of each construct was immobilized on glutathi-
one-agarose (Thermo Scientific) following the manufacturer’s
guidelines. 14-3-3-Labeled beads or control beads were incu-
bated in TBS containing EDTA-free Halt Protease and Phos-
phatase Inhibitor Mixture (Invitrogen) overnight at 4 °C. After
extensivewashing in TBS, captured proteins were eluted by 2
15min incubation with 10mM glutathione, followed by a single
elution using Laemmli sample buffer. All GST pulldown assays
were repeated twice with different lysates, but yielded similar
results.
Surface Plasmon Resonance (SPR) Analyses—A potential di-
rect interaction between 14-3-3 and various AQP2 peptides
corresponding to the last 44 amino acids of mouse AQP2 in
either unmodified, or phosphorylated at single sites corre-
sponding to Ser-256, Ser-264, or Ser-269 (Genscript, USA) was
studied by SPR analysis on a Biacore 3000 instrument, essen-
tially as described (35). Biacore type CM5 sensor chips were
activated with a 1:1 mixture of 0.2 M N-ethyl-N-(3-dimethyl-
aminopropyl)carbodiimide and 0.05 M N-hydroxysuccimide in
water according to instructions by the manufacturer. GST-14-
3-3 (Sino Biological Inc.) was immobilized in 10 mM sodium
acetate, pH 4.0, and the remaining binding sites were blocked
with 1 M ethanolamine, pH 8.5. A control flow cell was made by
performing the activation and blocking procedure only. Pep-
tides were dissolved in 10 mM Hepes, 150 mM NaCl, 2.0 mM
CaCl2, 1.0 mM EGTA, and 0.005% Tween 20, pH 7.4. Sample
and running buffers were identical. Regeneration of the sensor
chip after each analysis cycle was performed with 10 mM gly-
cine, pH 4.0, containing 20 mM EDTA and 500 mM NaCl.
14-3-3 Far Western Blotting (Overlay Assay)—mpkCCD14
cells were grown in dDAVP for 4 days, treated acutely with
dDAVP where indicated (description above), and AQP2 was
immunoprecipitated as previously described (23). Some sam-
ples were solubilized with 1% SDS for 10 min with heating at
60 °C, after which the SDSwas diluted to 0.1% using lysis buffer
before IP. IP samples, alongside various AQP2 peptides were
separated by SDS-PAGE and transferred to PVDF membrane.
Membranes were blocked in 5% skimmed milk in TBST for 1 h
at room temperature, before incubation overnight at 4 °Cwith 1

g/ml ofGST14-3-3 (SinoBiological Inc.) in 5%BSA inTBST.
After washing in TBST, membranes were incubated at room
temperature for 1 hwith anHRP-linkedGSTantibody (number
A00866, Genscript) before visualization using ECL detection.
RT-PCR and Real Time qRT-PCR—Total RNA was isolated
using the Ambion Ribopure kit (Invitrogen), treated with
DNase I (Invitrogen), and reverse transcribed using Superscript
II and random primers (Invitrogen); all steps were performed
according to the manufacturer’s instructions. A control reac-
tion without the reverse transcriptase enzyme was performed
to exclude genomic DNA amplification. Primer pairs utilized
were: AQP2 (5-TGGCTGTCAATGCTCTCCAC and 5-
GGAGCAGCCGGTGAAATAGA); 18S RNA (5-GGATCCA-
TTGGAGGGCAAGT and 5-ACGAGCTTTTTAACTGCA-
GCAA); 14-3-3 (5-TGGATAAGAGTGAGCTGGTACA
and 5-CGTGTCCCTGCTCTGTTACG); 14-4-4 (5-AGTG-
ACATTGCGATGACAGAAC and 5-ACGGTCGGGGGAA-
TTAAGAAT); 14-3-3 (5-CCAAGAGGCGTTTGATATA-
AGCA and AAAAGCCGTTTTAGCCAGTGT), 14-3-3 (5-
14-3-3 Regulation of AQP2
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ACGAAGATCGAAATCTCCTCTCT and 5-CCGGTAGG-
CTTTAACTTTCTCCA); 14-3-3 (5-TGTGTGCGACACT-
GTGCTC and 5-TCGGCTAGGTAGCGGTAGTAG), and
14-3-3 (5-AAAAGTTCTTGATCCCCAATGC and 5-TGT-
GACTGGTCCACAATTCCTT) spanned an exon-exon junc-
tion or an intron. -Actin was used as a positive control for
cDNA integrity and cDNA frommouse cerebellumwas used as
a positive control for 14-3-3 isoform amplification. Specificity
of the amplified products was determined using melting curve-
analysis software, gel electrophoresis, and sequencing. Ampli-
fication was performed using the cDNA equivalent of 5 ng of
RNA, 5 pmol of each primer and either HotStar Taq polymer-
ase (Qiagen) or SYBR Green I Master Taq (Roche Applied Sci-
ence). Cycling conditions were: 95 °C for 5 min, followed by 40
cycles of 95 °C for 10 s, 62 °C for 20 s, and 72 °C for 30s. qRT-
PCR reactions were run on a LightCycler 480 (Roche), with
fluorescence measured at the end of each elongation step to
calculateCt values. Relative quantitation of gene expressionwas
determined using the comparative Ct method, with validation
experiments performed to determine that amplification effi-
ciencies were equal between control and experimental groups.
Signals for ribosomal 18S amplified in parallel were used to
normalize for differences in the amount of starting cDNA.
Immunoblotting—Standard procedures were utilized for
sample preparation and SDS-PAGE. Immunoblots were devel-
oped using ECL detection and signal intensity in specific bands
were quantified using Image Studio Lite (Qiagen) densitometry
analysis.
Statistics—All quantitative experiments on cultured cells
were performed on at least 2 wells of cells in 3 different exper-
iments. Data were tested for normal distribution using the
D’Agostino-Pearson omnibus test and GraphPad Prism Soft-
ware. Data fitting a normal distribution were analyzed using
one-way analysis of variance followed by Tukey’s Multiple
Comparison Test. Multiple comparison tests were applied only
when a significant difference (p 0.05) was determined in the
analysis of variance. Data not fitting a normal distribution were
assessed using a nonparametricKruskal-Wallis test. All data are
presented as mean S.E.
Results
14-3-3 Isoforms in mpkCCD14 Cells and Mouse Kidney—Ini-
tial RT-PCR using mouse isoform-specific primers determined
that all known 14-3-3 isoforms, with the exception of , were
present at high levels in mpkCCD14 cells and mouse kidney
cortex and inner medulla (Fig. 1A). To confirm the expression
of 14-3-3 isoforms (except ) at the protein level, isoform-spe-
cific antibodies were utilized. HEK cells transfected with vari-
ous HA-tagged 14-3-3 isoforms followed by Western blotting
on cell lysates confirmed that the endogenous levels of all iso-
FIGURE 1. Identification of 14-3-3 isoforms inmpkCCD14 cells andmouse
kidney. A, RT-PCR using mouse 14-3-3 isoform-specific primers on mouse
cerebellum, mpkCCD14 cells, mouse kidney cortex (CTX), and inner medulla
(IM). Primers against actin were used as a positive control. All 14-3-3 isoforms
with the exception of were detected. B, specificity of 14-3-3 isoform-selec-
tive antibodies. HEK cells were transfected with various HA-tagged 14-3-3
isoforms followed by Western blotting on cell lysates using 14-3-3 isoform-
selective antibodies. In HEK cells, the endogenous levels of all isoforms are
relatively high. Using the various isoform selective antibodies, an additional
higher molecular weight band representing the HA tag form of 14-3-3 was
identified only using corresponding antibodies.C, immunoblotting ofmouse
cerebellum, mpkCCD14 cells, mouse kidney cortex (CTX), and inner medulla
(IM) protein homogenates using 14-3-3 isoform-specific antibodies con-
firmed the RT-PCR results.
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forms in HEK cells are relatively high, and that the antibodies
utilized were isoform specific (Fig. 1B). Inmouse kidney cortex,
inner medulla, and mpkCCD14 cell homogenates, endogenous
expression of all 14-3-3 isoforms identified at the message level
were confirmed (Fig. 1C).
Similar isoform-specific antibodies were used to examine the
subcellular distribution of various 14-3-3 proteins in mouse
kidney inner medulla collecting duct (IMCD) cells. Technical
issues prevented analysis of the antibodies using formaldehyde-
fixed paraffin-embedded tissue (not shown). After optimiza-
tion, some of the antibodies worked successfully using cryosec-
tions (Fig. 2). Each of the isoforms detected successfully using
immunohistochemistry had various and punctuate distribu-
tions in IMCD cells, suggesting distinct roles. Although 14-3-
3, -, and - were predominantly distributed throughout the
cytoplasm, 14-3-3 was localized near the apical plasma mem-
brane, with a distribution similar to AQP2.
Regulation of 14-3-3 Isoform Abundance by AVP—mpkCCD14
cells were grow on semi-permeable supports and treated for 24,
48, or 72 hwith dDAVP. qRT-PCRwas performed usingmouse
14-3-3 isoform-selective primers. dDAVP treatment signifi-
cantly increased AQP2 mRNA levels relative to controls from
24 to 72 h (Table 1). Concerning the isoforms,mRNA increased
for the  (24–72 h) and  (48–72 h) isoforms, whereas mRNA
for  (24–74 h) and  (48–72 h) isoforms were decreased.
AQP2 and 14-3-3 protein levels were examined using the iso-
form-specific antibodies and a similar experimental set-up (Fig.
3). AQP2 protein levels increased from 24 to 72 h. In alignment
with themRNAdata, protein levels of 14-3-3 (24–72 h) and -
(48–72 h) isoforms were significantly increased by dDAVP,
whereas  (24–74 h) and  (72 h) protein abundances were
significantly decreased following dDAVP treatment.
AQP2 Co-immunoprecipitates with 14-3-3 in mpkCCD14
Cells—To test the hypothesis that 14-3-3 andAQP2 interact, IP
studies on mpkCCD14 cell lysates were performed. After opti-
mization of experimental conditions (alterations in divalent
cation concentration and detergent type/concentration in lysis
buffer, data not shown), a reproducible AQP2 and 14-3-3 inter-
action was identified (Fig. 4). AQP2 could be detected in sam-
ples immunoprecipitated using either an AQP2-specific anti-
body (Fig. 4A), or with an antibody targeting total 14-3-3 (does
not differentiate between isoforms), but not with an AQP1-
specific antibody (negative control). Similarly, 14-3-3 could be
detected in 14-3-3 or AQP2 IP samples, but not AQP1 IP sam-
ples (Fig. 4B).
AQP2 Interaction with 14-3-3 Is Regulated by AVP—To
examine if the AQP2 and 14-3-3 interaction was regulated by
AVP, mpkCCD14 cells were cultured in dDAVP for 3 days (to
increase AQP2 levels), followed by acute stimulation with
dDAVP (see “Experimental Procedures”). Following 20 min
dDAVP stimulation, the interaction between AQP2 and 14-3-3
was enhanced, with a greater quantity of 14-3-3 immunoiso-
lated using an AQP2 antibody, or conversely, a greater quantity
of AQP2 immunoisolated using a 14-3-3 antibody (Fig. 5A).
Quantification data from 3 individual immunoprecipitations is
shown in Fig. 5, B and C.
AVP Washout in the Presence of Phosphatase Inhibitors Pre-
serves the AQP2 and 14-3-3 Interaction—We previously deter-
mined that several AQP2 protein/protein interactions are de-
pendent on the phosphorylation status of AQP2 at Ser-256 and
Ser-269 (29) and that the phosphorylation of AQP2 (particu-
larly at Ser-269) can be enhanced and prolonged during AVP
washout by inhibition of specific protein phosphatases using
OA and CA (23). To examine a potential role of phosphoryla-
FIGURE 2. Subcellular distribution of AQP2, 14-3-3, -, -, and - in mouse kidney IMCD cells. Isoform-specific antibodies were utilized on cryosections
ofmouse kidney. The various 14-3-3 isoforms (green) had alternative punctuate distributions in IMCD cells. 14-3-3 had a similar distribution similar to AQP2 at
the apical plasma membrane. Scale bar is 10 
m.
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tion in mediating the interaction between AQP2 and 14-3-3,
mpkCCD14 cells were acutely stimulatedwith dDAVP followed
by a washout period in the presence or absence of OA and CA.
Similarly to what has been observed inMDCK cells (23), AQP2
Ser(P)-269 levels in mpkCCD14 total cell lysates were signifi-
cantly higher after acute dDAVP treatment, but were subse-
quently reduced following dDAVP washout (Fig. 6, A and B).
However, AQP2 Ser(P)-269 levels remained significantly
higher after dDAVP washout in the presence of CA and OA.
Immunoprecipitations on the same cell lysates demonstrated
once again a 14-3-3/AQP2 interaction that was enhanced fol-
lowing dDAVP stimulation (compare Figs. 5 and 6A). Although
this interaction was reduced following dDAVP washout, the
interaction remained significantly higher if the washout was
performed in the presence of CA and OA (Fig. 6C).
14-3-3 and - Interact with AQP2—Technical issues (same
species antibodies) prevented us performing a co-IP using the
isoform-selective antibodies. Therefore, to determine which
isoforms of 14-3-3may interact with AQP2, HEK293T cells (do
not expressAQP2) co-transfectedwith variousHA-14-3-3 con-
structs and AQP2 were stimulated with forskolin (to mimic
dDAVP-induced increases in cAMP) followed by immunopre-
TABLE 1
Effects of long term dDAVP (1 ng) treatment of mpkCCD cells on AQP2 and 14-3-3 isoformmRNA levels
Data are mean S.E. from semi-qRT-PCR studies.
24 h 48 h 72 h
Control dDAVP Control dDAVP Control dDAVP
AQP2 1.00 0.00 1.72 0.16a 1.01 0.17 3.03 0.19a,b 1.17 0.16 3.10 0.34a
14-3-3 1.00 0.00 1.54 0.20a 1.03 0.18 1.62 0.17a 0.83 0.13 1.75 0.22a
14-3-3 1.00 0.00 1.04 0.19 0.95 0.19 1.01 0.21 0.96 0.23 0.96 0.17
14-3-3 1.00 0.00 1.01 0.11 0.99 0.07 0.97 0.07 0.96 0.11 1.02 0.08
14-3-3 1.00 0.00 0.70 0.09a 0.99 0.10 0.55 0.08a 1.07 0.11 0.58 0.16a
14-3-3 1.00 0.00 1.05 0.10 0.99 0.05 1.35 0.04a 1.01 0.08 1.69 0.04a,b
14-3-3 1.00 0.00 1.00 0.09 0.94 0.12 0.75 0.07a 0.97 0.07 0.57 0.09a
a Indicates p 0.05 compared to the time-matched control group.
b Indicates p 0.05 compared to the previous time point of treatment.
FIGURE 3. Regulation of AQP2 and 14-3-3 isoform abundance by AVP.mpkCCD14 cells were grown on semi-permeable supports and treated for 24, 48, or
72 h with dDAVP followed by immunoblotting with AQP2 or various 14-3-3 isoform selective antibodies. * indicates p 0.05 relative to the control condition.
# indicates p 0.05 from the group as indicated.
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cipitation (Fig. 7). Similar tompkCCD14 cells, inAQP2 express-
ing HEK293 cells, AQP2 was detected in immunoprecipitates
using a pan 14-3-3 antibody (detects all 14-3-3 isoforms). How-
ever, only in HEK293T cells expressing HA-14-3-3 or -was it
possible to co-IP AQP2 using an anti-HA antibody, suggesting
that AQP2 interacts selectively with these 14-3-3 isoforms (Fig.
7, lower panel). To confirm these potential selective interac-
tions, we performedGST pulldown assays with 14-3-3, -, and
- as bait and dDAVP-treated mpkCCD14 cell lysates as prey
(Fig. 8). Non-coated control beads or 14-3-3-coated beads dis-
played no interactions with AQP2 (Fig. 8A). In contrast, AQP2
was consistently identified in eluates from either 14-3-3- or
--coated beads (Fig. 8, B and C), suggesting that AQP2 selec-
tively interacts with these isoforms directly. AQP2 was not
identified in eluates from similar GST pulldown assays when
thempkCCD14 cell lysate preywas preincubatedwith-protein
phosphatase 1 for 60min (not shown), indicating a role of phos-
phorylation in the AQP2/14-3-3 interaction.
Phosphorylation of AQP2 at Ser-256 Is Critical for 14-3-3
Interactions—AQP2 contains four highly conserved and AVP-
regulated phosphorylation sites at Ser-256, Ser-261, Ser-264,
FIGURE 4. AQP2 interaction with 14-3-3 in mpkCCD14 cells. A, a represen-
tative immunoblot from samples immunoprecipitated from mpkCCD14 cell
lysates using anAQP2-specific antibody. Both total 14-3-3 andAQP2 could be
detected.B, a representative immunoblot fromsamples immunoprecipitated
using a 14-3-3 specific antibody. Both total AQP2 and 14-3-3 could be
detected. Neither 14-3-3 or AQP2 were detected in samples immunoprecipi-
tated with AQP1 (negative control).
FIGURE 5.AQP2 interactionwith 14-3-3 is regulated by AVP. Immunopre-
cipitations were performed on lysates from mpkCCD14 cells cultured in
dDAVP for 3 days, followed by acute stimulation with dDAVP for 20 min. A,
representative immunoblotting of control conditions (C) or following acute
dDAVP stimulation (V). Each lane represents a separate immunoprecipitation
using antibodies as highlighted. B and C, summary quantification data of
immunoprecipitations demonstrates the enhanced interaction between
AQP2 and 14-3-3 following dDAVP treatment. * indicates p 0.05 relative to
the control condition.
FIGURE 6. AVP washout in the presence of phosphatase inhibitors pre-
serves theAQP2and14-3-3 interaction.mpkCCD14 cellswere acutely stim-
ulated with dDAVP followed by a washout period in the presence or absence
of the inhibitors okadaic acid and calyculin A. Immunoprecipitation was per-
formed using AQP2. A, representative immunoblotting demonstrated a
14-3-3 andAQP2 interaction thatwasenhanced followingdDAVP stimulation
(V) relative to control (C). This interaction was reduced following dDAVP
washout (WO), but remained significantly higher in the presence of inhibitors
(Inh). AQP2 Ser(P)-269 levels in cell lysates followed a similar trend. B and C,
summary quantification data of Ser(P)-269 AQP2 levels and 14-3-3/AQP2
interaction under the different experimental conditions. * indicates p 0.05
relative to the control condition or from the group as indicated.
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and Ser-269 (Thr in human) at its carboxyl-terminal tail.
Although early analysis of 14-3-3 interactions proposed three
fundamental binding motifs (or criteria) within target phos-
phoproteins: 1) RSX(pS)XP (mode I); 2) RX(F/Y)X(pS)XP
(mode II) and; 3) a phosphorylated residue as the penultimate
residue in the carboxyl-terminal tail of the protein target (5, 36),
subtle variations of these motifs make prediction of 14-3-3
binding sites difficult. Recently, based on the observations that
the majority of human 14-3-3 interacting phosphoproteins are
2R-ohnologues (37), newmethods have been developed to pre-
dict 14-3-3-binding phosphosites using a variety of algorithms
(38). Analysis of human AQP2 scored highly the region sur-
rounding the Ser-256 site of AQP2 (EVRRRQpSVELH) as a
14-3-3 interacting motif using three complimentary methods
(scores: artificial neural network 0.742 (cut-off 0.55); posi-
tion-specific scoring matrix  1.155 (cut-off  0.80); support
vector machine  0.616 (cut-off  0.25); consensus  0.838
(cut-off  0.50)). Similar high scores were obtained using
mouse or rat AQP2 for analysis. These bioinformatics data cou-
pled with the protein pulldown data support a model where
AQP2 phosphorylation mediates the 14-3-3 interaction. To
examine whether any of the known phosphorylation sites in
AQP2 may be involved, HEK293T cells (do not express AQP2)
wereco-transfectedwithwild-typeAQP2orvariousAQP2phos-
phorylation deficient mutants (S256A, S261A, S264A, S269A)
and HA-14-3-3 and - constructs. Cells were stimulated with
forskolin followed by immunoprecipitation. In 14-3-3-trans-
fected cells (Fig. 9A) and in samples immunoprecipitated with
an HA antibody, AQP2 could not be detected in cells trans-
fected with AQP2 S256A, and less AQP2 was observed in cells
transfectedwith S264A or S269A. Conversely, in AQP2 IP sam-
ples, 14-3-3 could not be detected in cells transfected with
AQP2 S256A, and less 14-3-3 was detected in cells transfected
with S264A or S269A. In 14-3-3-transfected cells (Fig. 9B) and
in samples immunoprecipitated with an HA antibody, AQP2
could not be detected in cells transfected with AQP2 S256A or
S269A. Conversely, in AQP2 IP samples, 14-3-3 could not be
detected in cells transfectedwithAQP2 S256Aor S269A. These
data suggest that Ser-256, Ser-264, and Ser-269 sites in AQP2
are important for the 14-3-3 interaction.
Direct Interaction of AQP2 Carboxyl-terminal Tail with
14-3-3—The potential for AQP2 to directly interact with
14-3-3 was studied using SPR. As demonstrated in Fig. 10A, a
44-amino acid peptide corresponding to the carboxyl-terminal
FIGURE 7. 14-3-3 and - interact with AQP2 in HEK293T cells. HEK293T cells were co-transfected with various HA-14-3-3 constructs and AQP2, stimulated
with forskolin and subject to immunoprecipitationwith various antibodies. In immunoprecipitatesusinga total 14-3-3 antibody,AQP2wasdetected.However,
only in HEK293T cells expressing HA-14-3-3 or - immunoprecipitated using an anti-HA antibody was AQP2 identified, suggesting that AQP2 interacts
selectively with these 14-3-3 isoforms.
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44 amino acids of AQP2 and phosphorylated at Ser-256 repro-
ducibly associated with immobilized 14-3-3, with an apparent
Kd of 0.5 
M. All other peptides (lacking Ser-256 phosphoryla-
tion) showed no significant interaction. 14-3-3 overlay assays
(Fig. 10B) using 14-3-3 on immunoisolated AQP2 or the car-
boxyl-terminal peptides confirmed that a direct interaction,
which was dependent on Ser-256 phosphorylation, was possi-
ble. In addition to the 14-3-3 signal at a molecular weight cor-
responding to AQP2, the presence of additional bands in AQP2
co-immunoprecipitation samples suggests that other proteins
that associate with AQP2may also interact with 14-3-3. Similar
results were observed using 14-3-3 during the overlay (not
shown).
Stable Knockdown of 14-3-3 and - in mpkCCD14 Cells
Alters AQP2 Protein Abundances and Half-lives—To examine
the role of 14-3-3 and - in regulation of AQP2, knockdown of
each isoform individually in mpkCCD14 cells using various
14-3-3 isoform-specific shRNA constructs was undertaken.
Initial transient transfections were successful in identifying the
most potent shRNAs for 14-3-3 knockdown (data not shown),
which were subsequently used to generate stable knockdown
mpkCCD14 cells. Several independent cell populations were
characterized by qRT-PCR (Fig. 11A) and Western blotting
using isoform-selective antibodies (Fig. 11B). Line T1 and Z2
were utilized for subsequent studies. When grown on semi-
permeable supports for 10 days (dDAVPpresent for last 3 days),
the T1 and Z2 cell lines showed no obvious morphological dif-
ferences to control mpkCCD14 cells and there were no signifi-
cant differences in their transepithelial electrical resistances;
control  8845  73 /cm2, T1  8845  73 /cm2, Z1 
8620 173/cm2. In total protein homogenates, AQP2 levels
were significantly increased in T1 cells relative to control
mpkCCD14 cells, whereas in Z2 cells AQP2 levels were
decreased by	50% (Fig. 12A). No significant differences in the
abundance of the V2R, or in AQP2 mRNA levels (qRT-PCR)
between control, T1, or Z2 cell lines were detected (Fig. 13),
suggesting that the effects of 14-3-3 or - knockdown were
either on AQP2 translation efficiency or AQP2 degradation
rate. To examine the latter, cycloheximide studies (inhibitor of
protein translation) were performed in control, T1 and Z2
mpkCCD14 cells (see “Experimental Procedures”) and AQP2
protein levels were examined by immunoblotting (Fig. 12C).
The calculated AQP2 protein half-life (Fig. 12D) in control
mpkCCD14 cells was 4.02 h (95% confidence interval 3.60 to
4.50), compared with 5.84 h (95% confidence interval 5.18 to
6.69) in T1 cells and 2.96 (95% confidence interval 2.66 to 3.34)
h in Z2 cells, indicating that the altered AQP2 protein abun-
dances in the various cell lines are partially due to significantly
altered protein stability.
Stable Knockdown of 14-3-3 and - in mpkCCD14 Cells
Alters AQP2 Membrane Targeting, Phosphorylation, and
Ubiquitylation—The abundance of AQP2 on the plasmamem-
brane is regulated by a complex interplay between AQP2 phos-
phorylation and ubiquitylation. To examine a potential role of
14-3-3 and - in these mechanisms the plasma membrane
abundance, ubiquitylation, and phosphorylation status of
AQP2 in the various mpkCCD14 cell lines was examined. To
mimic a physiological setting, cells were examined under con-
trol, acute dDAVP stimulated, or acute dDAVP stimulated fol-
lowed by dDAVP washout conditions. Representative immu-
noblotting data are shown in Fig. 14A. In control mpkCCD14
cells, the abundance of AQP2 on the apical plasma membrane
significantly increased following 20 min of dDAVP treatment,
followed by a reduction 30 min after dDAVP washout (Fig.
14B). A similar pattern of AQP2 distribution was observed in
T1 cells, however, the plasmamembrane levels of AQP2 follow-
FIGURE 8.GST pulldown assays using 14-3-3 and - and -. GST pulldown
assays were performed with dDAVP-treated mpkCCD14 cell lysates as prey
and GST-14-3-3, GST-14-3-3, or GST-14-3-3 as bait. Immunoblotting was
performedusing antibodies detecting total AQP2orGST. Non-coated control
beads or 14-3-3 (A) coated beads displayed no interactions with AQP2,
whereasAQP2was consistently identified in eluates fromeither 14-3-3 (B) or
- (C) coated beads. S-1 and S-2 represent different experimental samples. FT
represents flow-through after binding of bait to beads or after incubation of
beads with lysate prey. Elutions 1 and 2 are successive elutions with 10 mM
glutathione, whereas elution 3 is a single elution using Laemmli sample
buffer.
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ing dDAVP stimulation were significantly higher than in con-
trol mpkCCD14 cells (Fig. 14, B and C). Although AQP2 redis-
tribution in Z2 cells followed a similar trend as in control and
T1 mpkCCD14 cells (Fig. 14, B and C), the AQP2 plasma mem-
brane abundances were not significantly different under any of
the examined conditions. Under identical conditions, ubiquity-
lated AQP2 levels in all 3 cell lines were significantly enhanced
during dDAVP and dDAVP washout conditions (Fig. 14D).
Furthermore, ubiquitylated AQP2 levels were 	2-fold higher
in Z2 cells compared with control and T1mpkCCD14 cells (Fig.
14E), providing an explanation for the decreased AQP2 protein
half-life in these cells (Fig. 12). Similarly to previous observa-
tions (Fig. 6), in all 3 cell lines Ser(P)-269 AQP2 levels in total
cell lysates were significantly increased after acute dDAVP
treatment, but were reduced following dDAVP washout (Fig.
14F). The levels of Ser(P)-269 levels following dDAVP treat-
ment were significantly higher in T1 cells relative to dDAVP-
treatedmpkCCD14 cells (Fig. 14G), matching the greater AQP2
plasma membrane abundance under similar conditions.
Although Ser(P)-269 AQP2 levels were consistently reduced in
the Z2 cells, these did not reach significance (Fig. 14G).
Discussion
The water channel AQP2 is the AVP-regulated water chan-
nel of the kidney principal cells. AQP2 function is highly depen-
dentonitsphosphorylationstatus,whichmediatesvariousphos-
phorylation-dependent AQP2 protein/protein interactions
(29). In this study we examined the hypothesis that 14-3-3 pro-
teins, which often interact with phosphorylated proteins, can
modulate the function of AQP2.
All 14-3-3 isoforms, except, were detected inmouse kidney
andmpkCCD14 cells. The absence of correspondswith recent
large scale RNA sequencing studies of isolated kidney segments
from rat (12) or cDNA arrays of isolated rat IMCD (39).
Although redundancy among 14-3-3 isoforms has been
debated (40), 14-3-3, -, -, and - had distinct distributions in
mouse IMCD cells, suggesting that different isoforms fulfill dif-
ferent roles in these cells. In particular, the 14-3-3 isoform,
whose distributionwas similar toAQP2, is ideally placed to play
a role inAQP2 regulation. Although limited to the resolution of
confocalmicroscopy, the punctate distribution of  at the apical
plasma membrane is similar to that observed for AQP2 under
FIGURE 9. Phosphorylation of AQP2 at Ser-256 is critical for 14-3-3 interactions.HEK293T cells were co-transfected with wild-type AQP2 or various AQP2
phosphorylation deficient mutants (S256A, S261A, S264A, and S269A) and HA-14-3-3 or - constructs. A, in 14-3-3-transfected cells, in HA IP samples AQP2
could not be detected in cells transfected with AQP2 S256A, and less AQP2 was observed in cells transfected with S264A or S269A. Conversely, in AQP2 IP
samples, 14-3-3 could not be detected in cells transfected with AQP2 S256A, and less 14-3-3 was detected in cells transfected with S264A or S269A. B, in
14-3-3-transfected cells, in HA IP samples AQP2 could not be detected in cells transfectedwith AQP2 S256Aor S269A. Conversely, in AQP2 IP samples, 14-3-3
could not be detected in cells transfected with AQP2 S256A or S269A.
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certain conditions (24), where a proportion of AQP2 is located
in “endocytosis-resistant” membrane domains after AVP treat-
ment (41).
Selective alterations in 14-3-3 isoform expression by AVP
further indicated a link between AQP2 function and 14-3-3
proteins. AQP2 is an AVP-induced protein in vivo, with AVP
increasing AQP2 abundance via stimulating AQP2 gene tran-
scription (42). In mpkCCD14 cells, similarly to AQP2, 14-3-3
and - were increased in expression following long-term
dDAVP stimulation, whereas  and  expression levels were
decreased. An increase in  expression in IMCD cells following
long-term dDAVP treatment of rats has been observed previ-
ously (43). The finding that dDAVP increased 14-3-3 levels
fits well with the known role of AVP to increase collecting duct
NaCl transport (reviewed in Ref. 44). In principle, increased
14-3-3 would enhance the known 14-3-3 interaction with
Nedd4-2, thereby inhibiting Nedd4-2-mediated ENaC ubiqui-
tylation and ultimately increasing sodium transport (15, 18, 45).
The data collected from immunoprecipitation studies using
mpkCCD14 andHEKcells, combinedwith the results fromGST
pulldown assays strongly infers that AQP2 interacts with
14-3-3 and -. Furthermore, these selective 14-3-3 interac-
tions being phosphorylation-dependent are supported by 1) an
increased interaction of AQP2 with 14-3-3 following dDAVP
treatment in a time scale where AQP2 phosphorylation is
known to occur; 2) phosphatase inhibitors potentiating the
dDAVP-induced AQP2/14-3-3 interactions; 3) a loss of AQP2
in GST pulldowns following -phosphatase treatment of prey
lysates; 4) reduced AQP2/14-3-3 interactions in various AQP2
phosphorylation-deficientmutants; and 5) direct interaction of
only Ser(P)-256 peptides with immobilized 14-3-3. Overlay
assays and SPR analysis provided evidence that a direct 14-3-3/
AQP2 interaction was possible, which was critically dependent
on Ser-256 phosphorylation. However, as 14-3-3 is known to
associate with other proteins that can interact with AQP2, e.g.
AKAP, Nedd4-2, Hsp70, BiP, -actin, tropomyosin, PKA, and
PP1 (46–48), we cannot rule out that other proteins are
involved in, or possibly stabilize the interaction, as part of a
multiprotein complex. Interestingly, the interaction of AQP2
with 14-3-3 and - differs to other 14-3-3 membrane protein
interactions observed in the kidney, e.g. the sodium hydrogen
exchanger NHE1 association with 14-3-3 (49) and the UT-A
urea transporter association with 14-3-3 (13), providing addi-
tional evidence that 14-3-3 isoforms are not redundant but
rather play selective roles in modulating protein function.
Lentiviral mediated delivery of 14-3-3 or - shRNA con-
structs to mpkCCD14 cells uncovered selective, but complex,
roles of these isoforms in modulating AQP2 function. Knock-
FIGURE 10. The carboxyl-terminal tail of AQP2 can interact directly with
14-3-3.A,SPRanalysis of 14-3-3withvariouspolypeptides corresponding to
the carboxyl-terminal 44 amino acids of AQP2. The y axis indicates the differ-
ence between the sample and control runs in relative response units. A Ser-
256 phosphorylated AQP2 peptide (pS256-AQP2) reproducibly associated
with immobilized 14-3-3, with a Kd of 0.5 
M. B, 14-3-3 overlay assays on
immunoisolatedAQP2under control (C) or acutedDAVP (V) conditions.
SDS
indicates lysates were treated with 1% SDS before immunoisolation (see
“Experimental Procedures”). C, similar overlay assay on AQP2 carboxyl-termi-
nal peptides confirmed the dependence of Ser256 phosphorylation for the
AQP2/14-3-3 interaction.
FIGURE11.CharacterizationofmpkCCD14 cellswith stable knockdownof
14-3-3 and -. Lentivirus-mediated delivery of 14-3-3 and - shRNAs was
used to generate stable knockdownof individual isoforms inmpkCCD14 cells.
A, qRT-PCR analysis of mRNA levels of 14-3-3 or - in control (WT) or 6 inde-
pendent cell populations. B, Western blotting using isoform-selective anti-
bodies on the 3 independent cell populations with the lowest 14-3-3 mRNA
levels. * indicates p 0.05 relative to the WT cells.
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down of 14-3-3 resulted in increased AQP2 ubiquitylation,
decreased AQP2 half-life, and ultimately drastically reduced
AQP2 levels. These data suggest that 14-3-3 “protects” AQP2
from being ubiquitylated and directed into the degradation
pathway. The distinct localization of 14-3-3 suggests that this
“protection” occurs in the apical plasma membrane domain,
where otherwise ubiquitylation of AQP2 followed by endocytic
retrieval and subsequent degradation is initiated (30). What
potential mechanisms could be behind such a response? Previ-
ous studies from our group and others have shown that AVP-
induced phosphorylation of AQP2 at Ser-256 and Ser-269
mediates AQP2 membrane accumulation by decreasing the
rate ofAQP2 internalization, a process that ultimately results in
increased AQP2 protein half-life (23, 29). Therefore, it is inter-
esting to speculate one model (Fig. 15) where: 1) upon AVP
stimulation AQP2 undergoes phosphorylation at Ser-256 that
facilitates its trafficking to the plasma membrane; 2) at the
membrane AQP2 undergoes Ser-269 phosphorylation; 3) the
individual or combined effect of the two AQP2 phosphoryla-
tion events mediates an interaction with 14-3-3; and 4) the
AQP214-3-3 complex prevents or limits binding of an
unknown E3 ligase or an adapter protein to AQP2 thus reduc-
ing AQP2 ubiquitylation, internalization, and subsequent deg-
radation. In line with this mechanism, mutation of AQP2 at
Ser-256 or Ser-269 to alanine resulted in the complete absence,
or dramatically reduced interaction of AQP2 with 14-3-3,
respectively. Furthermore, AQP2 membrane abundance and
Ser-269 phosphorylation were reduced in the 14-3-3 knock-
down cells, suggesting a higher rate of internalization. Finally,
FIGURE 12. Stable knockdownof 14-3-3and - inmpkCCD14 cells altersAQP2protein abundances andhalf-life.A, representative immunoblots (IB) of AQP2,
14-3-3, 14-3-3, and 	-tubulin abundances in protein lysates from control mpkCCD14 cells or cells with stable knockdown of 14-3-3 or -. Each lane represents a
different sample.B, summaryquantificationdataofAQP2abundance. * indicatesp0.05 relative to the control cells.C, representative immunoblottingofAQP2and
	-tubulin in a cycloheximide (CHX) chase experiment. Elevated andprolongedAQP2protein levels were consistently observed in the  knockdownmpkCCD14 cells,
whereas they were reduced rapidly in the  knockdown cells.D, curves show summarized cycloheximide data fitted using nonlinear regression and a one-phase expo-
nentialdecayequation.AQP2abundance isnormalizedtozerotimepoint.Valuesareobtainedfrom4independentexperimentswithn3–6foreach individual timepoint.
FIGURE 13. Analysis of V2R protein and AQP2 mRNA levels in T1 and Z2
cell lines. A, protein abundance of the V2Rwas assessed by immunoblotting
of total protein homogenates from the 14-3-3 (T1) and 14-3-3 (Z2) knock-
down cell lines. B, no significant differences were detected in the abundance
of the V2R. C, no significant differences were detected in AQP2 mRNA levels
between control, T1 or Z2 cell lines.
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the dDAVP-induced increases in 14-3-3 abundance observed
in mpkCCD14 cells support a role for 14-3-3 in reducing the
degree of AQP2 degradation during long-term AVP stimula-
tion, thus aiding in the conservation of body water.
A simple model for the role of 14-3-3 in AQP2 regulation is
less obvious. Conversely to the effects of 14-3-3, knockdownof
14-3-3 resulted in significantly greater AQP2 abundance; a
result of increased AQP2 protein half-life. Surprisingly,
althoughAQP2 ubiquitylation levels in the 14-3-3 knockdown
mpkCCD14 cells were marginally decreased relative to control,
these effects were not significant; suggesting the possibility of
non-ubiquitin-dependent AQP2 degradation. Further studies
are required to examine this possibility. Despite no significant
reductions in AQP2 ubiquitylation levels, AQP2 levels on the
plasma membrane were significantly enhanced after dDAVP
treatment, accompanied by higher levels of pS269 AQP2. This
data points toward 14-3-3 recruiting/stabilizing a protein
phosphatase complex that specifically targets the Ser(P)-269
site of AQP2.Attractive possibilities are protein phosphatases 1
and 2A, which can dephosphorylate Ser(P)-269 AQP2 (23), and
can also interact with 14-3-3 proteins (47, 48). The possibility of
14-3-3 interacting with Ser(P)-269 is supported by the
reduced interaction of AQP2 S269A with 14-3-3 in HEK293
cells. Furthermore, our previous studies have indicated a
unique role for Ser(P)-269 AQP2 in reducing AQP2 endocyto-
sis despite no alterations in AQP2 ubiquitylation levels (23).
This “negative” modulatory role of 14-3-3 for AQP2 is sup-
ported by the decreased  levels observed in mpkCCD14 cells
following long-term dDAVP treatment.
What is the physiological role of the 14-3-3/AQP2 interac-
tion? Vasopressin stimulation of various animal models
induces phosphorylation of AQP2 at Ser-256, Ser-264, and Ser-
269, with Ser-256 phosphorylation acting as a “master switch”
that is needed for the subsequent downstreamphosphorylation
of AQP2 (21). Although the exact role of each of these phos-
phorylation sites in isolation is still not completely clear, the
Ser-256 site is critical for vasopressin-stimulated accumulation
of AQP2 on the plasma membrane and for the AQP2/14-3-3
interactions. This suggests that the interactions occur down-
streamof vasopressin signaling and, based on the localization of
the different isoforms, potentially even in alternative subcellu-
lar compartments. Whether a different pool of AQP2 binds at
any one time to 14-3-3/, resulting in both positive/negative
effects on AQP2 membrane abundance and function is not
known.However, it is likely that the dual 14-3-3 interactions act
in concert to fine-tune the amount of AQP2 on the plasma
membrane and helpmodulate the degree of water reabsorption
by the principal cell.
In conclusion, we have determined that an AVP-regulated
and phosphorylation-dependent interaction occurs between
AQP2 and 14-3-3 and -. These interactions play a divergent
role in modulating AQP2 trafficking, phosphorylation, ubiqui-
tylation, and degradation.Our studies confirm thatAQP2 func-
tion is highly dependent on phosphorylation-dependent pro-
tein interactions with its carboxyl-terminal domain and
furthermore, provide additional evidence that various isoforms
of 14-3-3 play divergent roles in the cell.
FIGURE 14. Stable knockdown of 14-3-3 and - in mpkCCD14 cells alters AQP2membrane targeting, phosphorylation, and ubiquitylation. The three
mpkCCD14 cell lines under control (C), acute dDAVP stimulated (V), or acute dDAVP stimulated followedbydDAVPwashout (V
WO) conditionswere assessed
for AQP2 membrane abundance via biotinylation, alongside analysis of AQP2 phosphorylation levels and ubiquitylation status. A, representative immuno-
blotting data of AQP2, pS269-AQP2, ubiquitin, total 14-3-3, 14-3-3, and 14-3-3 levels in the various fractions. B and C, summary quantification data for
biotinylated AQP2. D and E, summary quantification data for ubiquitylated AQP2. F and G, summary quantification data for pS269-AQP2. Each paired graph
represents data normalized and analyzed in two differentways to facilitate comparisons between the experimental conditionswithin an individual cell line, or
between individual cells lines for each experimental condition. * indicates p 0.05 relative to the control condition/cell line, or from the group as indicated.
FIGURE 15. Proposed models for 14-3-3 regulation of AQP2. A, upon AVP stimulation AQP2 undergoes phosphorylation at Ser-256 that facilitates its
trafficking to the plasma membrane. At the membrane AQP2 undergoes Ser-269 phosphorylation. The individual or combined effect of the two AQP2
phosphorylation events mediates an interaction with 14-3-3. The AQP214-3-3 complex prevents or limits binding of an unknown E3 ligase or an adapter
protein to AQP2 thus reducing AQP2 ubiquitylation, internalization, and subsequent degradation. B, upon AVP stimulation AQP2 undergoes phosphorylation
at Ser-256 (and possibly Ser-264) that facilitates its trafficking to the plasma membrane. At the membrane, AQP2 undergoes Ser-269 phosphorylation. The
individual or combined effect of the three AQP2 phosphorylation events mediates an interaction with 14-3-3, which recruits a protein phosphatase to AQP2
resulting in dephosphorylation and internalization.
14-3-3 Regulation of AQP2
2482 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 5•JANUARY 29, 2016
 at D
EF Consortium
 - U
niv Library of Southern D
enm
ark on June 9, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Author Contributions—R. A. F. conceived the study. H. B. M.O.,
J. E. S. H., T. A., M. A., N. M., M. T., S. K. M., and R. A. F. performed
the study. V. B. provided essential reagents and helped on study
design. H. B. M. O. and R. A. F. drafted the manuscript. All authors
read and approved the final manuscript.
Acknowledgments—Tina Drejer, Inger-Merete Paulsen, Christian
Westberg, Ahmed Basim Abduljabar, Helle Høyer, and Anne Marie
Bundsgaard are thanked for expert technical assistance. Michele
Tinti, Gavuthami Murugesan, and Carol MacKintosh are thanked
for helpful discussions on identifying 14-3-3 interaction motifs and
overlay assay conditions.
References
1. Mackintosh, C. (2004) Dynamic interactions between 14-3-3 proteins and
phosphoproteins regulate diverse cellular processes. Biochem. J. 381,
329–342
2. Fu, H., Subramanian, R. R., and Masters, S. C. (2000) 14-3-3 proteins:
structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 40,
617–647
3. Morrison, D. K. (2009) The 14-3-3 proteins: integrators of diverse signal-
ing cues that impact cell fate and cancer development. Trends Cell Biol.
19, 16–23
4. Muslin, A. J., Tanner, J.W., Allen, P.M., and Shaw, A. S. (1996) Interaction
of 14-3-3 with signaling proteins is mediated by the recognition of phos-
phoserine. Cell 84, 889–897
5. Johnson, C., Crowther, S., Stafford, M. J., Campbell, D. G., Toth, R., and
MacKintosh, C. (2010) Bioinformatic and experimental survey of 14-3-3-
binding sites. Biochem. J. 427, 69–78
6. Aitken, A. (2011) Post-translational modification of 14-3-3 isoforms and
regulation of cellular function. Semin. Cell Dev. Biol. 22, 673–680
7. Bridges, D., and Moorhead, G. B. (2005) 14-3-3 proteins: a number of
functions for a numbered protein. Science’s STKE 2005, re10
8. Dougherty, M. K., and Morrison, D. K. (2004) Unlocking the code of
14-3-3. J. Cell Sci. 117, 1875–1884
9. Wilker, E., and Yaffe, M. B. (2004) 14-3-3 proteins: a focus on cancer and
human disease. J. Mol. Cell. Cardiol. 37, 633–642
10. Pozuelo Rubio, M., Geraghty, K.M.,Wong, B. H.,Wood, N. T., Campbell,
D. G., Morrice, N., andMackintosh, C. (2004) 14-3-3-affinity purification
of over 200 human phosphoproteins reveals new links to regulation of
cellular metabolism, proliferation and trafficking. Biochem. J. 379,
395–408
11. Liang, S., Xu, Y., Shen, G., Liu, Q., Zhao, X., Xu, Z., Xie, X., Gong, F., Li,
R., and Wei, Y. (2009) Quantitative protein expression profiling of
14-3-3 isoforms in human renal carcinoma shows 14-3-3 epsilon is
involved in limitedly increasing renal cell proliferation. Electrophoresis
30, 4152–4162
12. Lee, J. W., Chou, C. L., and Knepper, M. A. (2015) Deep sequencing in
microdissected renal tubules identifies nephron segment-specific tran-
scriptomes. J. Am. Soc. Nephrol. 26, 2669–2677
13. Feng, X., Li, Z., Du, Y., Fu, H., Klein, J. D., Cai, H., Sands, J. M., and Chen,
G. (2015) Downregulation of urea transporter UT-A1 activity by 14-3-3
protein. Am. J. Physiol. Renal Physiol. 309, F71–F78
14. Bhalla, V., Daidié, D., Li, H., Pao, A. C., LaGrange, L. P., Wang, J., Vande-
walle, A., Stockand, J. D., Staub, O., and Pearce, D. (2005) Serum- and
glucocorticoid-regulated kinase 1 regulates ubiquitin ligase neural precur-
sor cell-expressed, developmentally down-regulated protein 4-2 by induc-
ing interaction with 14-3-3.Mol. Endocrinol. 19, 3073–3084
15. Staub, O., Gautschi, I., Ishikawa, T., Breitschopf, K., Ciechanover, A.,
Schild, L., and Rotin, D. (1997) Regulation of stability and function of the
epithelialNa
 channel (ENaC) by ubiquitination.EMBO J. 16, 6325–6336
16. Chandran, S., Li, H., Dong,W., Krasinska, K., Adams, C., Alexandrova, L.,
Chien, A., Hallows, K. R., and Bhalla, V. (2011) Neural precursor cell-
expressed developmentally down-regulated protein 4-2 (Nedd4-2) regu-
lation by 14-3-3 protein binding at canonical serum and glucocorticoid
kinase 1 (SGK1) phosphorylation sites. J. Biol. Chem. 286, 37830–37840
17. Ichimura, T., Yamamura, H., Sasamoto, K., Tominaga, Y., Taoka, M.,
Kakiuchi, K., Shinkawa, T., Takahashi, N., Shimada, S., and Isobe, T.
(2005) 14-3-3 proteinsmodulate the expression of epithelialNa
 channels
by phosphorylation-dependent interaction withNedd4-2 ubiquitin ligase.
J. Biol. Chem. 280, 13187–13194
18. Liang, X., Butterworth, M. B., Peters, K. W., Walker, W. H., and Frizzell,
R. A. (2008) An obligatory heterodimer of 14-3-3 and 14-3-3 is required
for aldosterone regulation of the epithelial sodium channel. J. Biol. Chem.
283, 27418–27425
19. Barile, M., Pisitkun, T., Yu, M. J., Chou, C. L., Verbalis, M. J., Shen, R. F.,
and Knepper, M. A. (2005) Large scale protein identification in intracel-
lular aquaporin-2 vesicles from renal innermedullary collecting duct.Mol.
Cell Proteomics 4, 1095–1106
20. Moeller, H. B., and Fenton, R. A. (2012) Cell biology of vasopressin-regu-
lated aquaporin-2 trafficking. Pflugers Arch. 464, 133–144
21. Hoffert, J. D., Fenton, R. A., Moeller, H. B., Simons, B., Tchapyjnikov, D.,
McDill, B. W., Yu, M. J., Pisitkun, T., Chen, F., and Knepper, M. A. (2008)
Vasopressin-stimulated increase in phosphorylation at Ser-269 potenti-
ates plasma membrane retention of aquaporin-2. J. Biol. Chem. 283,
24617–24627
22. Hoffert, J. D., Pisitkun, T.,Wang,G., Shen, R. F., andKnepper,M.A. (2006)
Quantitative phosphoproteomics of vasopressin-sensitive renal cells: reg-
ulation of aquaporin-2 phosphorylation at two sites. Proc. Natl. Acad. Sci.
U.S.A. 103, 7159–7164
23. Moeller, H. B., Aroankins, T. S., Slengerik-Hansen, J., Pisitkun, T., and
Fenton, R. A. (2014) Phosphorylation and ubiquitylation are opposing
players in regulating endocytosis of the water channel aquaporin-2. J. Cell
Sci. 127, 3174–3183
24. Moeller, H. B., Knepper, M. A., and Fenton, R. A. (2009) Serine 269 phos-
phorylated aquaporin-2 is targeted to the apical membrane of collecting
duct principal cells. Kidney Int. 75, 295–303
25. Hoffert, J. D., Nielsen, J., Yu, M. J., Pisitkun, T., Schleicher, S. M., Nielsen,
S., and Knepper, M. A. (2007) Dynamics of aquaporin-2 serine-261 phos-
phorylation in response to short-term vasopressin treatment in collecting
duct. Am. J. Physiol. Renal Physiol. 292, F691–700
26. Fenton, R. A., Moeller, H. B., Hoffert, J. D., Yu, M. J., Nielsen, S., and
Knepper, M. A. (2008) Acute regulation of aquaporin-2 phosphorylation
at Ser-264 by vasopressin. Proc. Natl. Acad. Sci. U.S.A. 105, 3134–3139
27. Rice, W. L., Zhang, Y., Chen, Y., Matsuzaki, T., Brown, D., and Lu, H. A.
(2012) Differential, phosphorylation dependent trafficking of AQP2 in
LLC-PK1 cells. PloS One 7, e32843
28. van Balkom, B.W., Savelkoul, P. J., Markovich, D., Hofman, E., Nielsen, S.,
van der Sluijs, P., and Deen, P. M. (2002) The role of putative phosphory-
lation sites in the targeting and shuttling of the aquaporin-2 water chan-
nel. J. Biol. Chem. 277, 41473–41479
29. Moeller, H. B., Praetorius, J., Rützler, M. R., and Fenton, R. A. (2010)
Phosphorylation of aquaporin-2 regulates its endocytosis and protein-
protein interactions. Proc. Natl. Acad. Sci. U.S.A. 107, 424–429
30. Kamsteeg, E. J., Hendriks, G., Boone, M., Konings, I. B., Oorschot, V., van
der Sluijs, P., Klumperman, J., and Deen, P. M. (2006) Short-chain ubiq-
uitination mediates the regulated endocytosis of the aquaporin-2 water
channel. Proc. Natl. Acad. Sci. U.S.A. 103, 18344–18349
31. Fenton, R. A., Brønd, L., Nielsen, S., and Praetorius, J. (2007) Cellular and
subcellular distribution of the type-2 vasopressin receptor in the kidney.
Am. J. Physiol. Renal Physiol. 293, F748–760
32. Yu, M. J., Miller, R. L., Uawithya, P., Rinschen, M. M., Khositseth, S.,
Braucht, D.W., Chou, C. L., Pisitkun, T., Nelson, R.D., andKnepper,M.A.
(2009) Systems-level analysis of cell-specific AQP2 gene expression in
renal collecting duct. Proc. Natl. Acad. Sci. U.S.A. 106, 2441–2446
33. Loo, C. S., Chen, C. W., Wang, P. J., Chen, P. Y., Lin, S. Y., Khoo, K. H.,
Fenton, R. A., Knepper, M. A., and Yu, M. J. (2013) Quantitative apical
membrane proteomics reveals vasopressin-induced actin dynamics in col-
lecting duct cells. Proc. Natl. Acad. Sci. U.S.A. 110, 17119–17124
34. Tamma, G., Lasorsa, D., Ranieri, M., Mastrofrancesco, L., Valenti, G., and
Svelto, M. (2011) Integrin signaling modulates AQP2 trafficking via Arg-
Gly-Asp (RGD) motif. Cell. Physiol. Biochem. 27, 739–748
35. Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H. J.,
14-3-3 Regulation of AQP2
JANUARY 29, 2016•VOLUME 291•NUMBER 5 JOURNAL OF BIOLOGICAL CHEMISTRY 2483
 at D
EF Consortium
 - U
niv Library of Southern D
enm
ark on June 9, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Law, S. K., and Moestrup, S. K. (2001) Identification of the haemoglobin
scavenger receptor. Nature 409, 198–201
36. Panni, S., Montecchi-Palazzi, L., Kiemer, L., Cabibbo, A., Paoluzi, S., San-
tonico, E., Landgraf, C., Volkmer-Engert, R., Bachi, A., Castagnoli, L., and
Cesareni, G. (2011) Combining peptide recognition specificity and con-
text information for the prediction of the 14-3-3-mediated interactome in
S. cerevisiae and H. sapiens. Proteomics 11, 128–143
37. Tinti, M., Johnson, C., Toth, R., Ferrier, D. E., and Mackintosh, C. (2012)
Evolution of signal multiplexing by 14-3-3-binding 2R-ohnologue protein
families in the vertebrates. Open Biol. 2, 120103
38. Madeira, F., Tinti, M., Murugesan, G., Berrett, E., Stafford, M., Toth, R.,
Cole, C., MacKintosh, C., and Barton, G. J. (2015) 14-3-3-Pred: improved
methods to predict 14-3-3-binding phosphopeptides. Bioinformatics 31,
2276–2283
39. Uawithya, P., Pisitkun, T., Ruttenberg, B. E., and Knepper, M. A. (2008)
Transcriptional profiling of native inner medullary collecting duct cells
from rat kidney. Physiol. Genomics 32, 229–253
40. Paul, A. L., Denison, F. C., Schultz, E. R., Zupanska, A. K., and Ferl, R. J.
(2012) 14-3-3 phosphoprotein interaction networks: does isoform diver-
sity present functional interaction specification? Front. Plant Sci. 3, 190
41. Bouley, R., Hawthorn, G., Russo, L. M., Lin, H. Y., Ausiello, D. A., and
Brown, D. (2006) Aquaporin 2 (AQP2) and vasopressin type 2 receptor
(V2R) endocytosis in kidney epithelial cells: AQP2 is located in “endocy-
tosis-resistant” membrane domains after vasopressin treatment. Biol. Cell
98, 215–232
42. Kortenoeven, M. L., Trimpert, C., van den Brand, M., Li, Y., Wetzels, J. F.,
and Deen, P. M. (2012) In mpkCCD cells, long-term regulation of aqua-
porin-2 by vasopressin occurs independent of protein kinase A and CREB
but may involve Epac. Am. J. Physiol. Renal Physiol. 302, F1395–1401
43. Pisitkun, T., Bieniek, J., Tchapyjnikov, D., Wang, G., Wu, W. W., Shen,
R. F., and Knepper, M. A. (2006) High-throughput identification of IMCD
proteins using LC-MS/MS. Physiol. Genomics 25, 263–276
44. Kortenoeven, M. L., Pedersen, N. B., Rosenbaek, L. L., and Fenton, R. A.
(2015) Vasopressin regulation of sodium transport in the distal nephron
and collecting duct. Am. J. Physiol. Renal Physiol. 309, F280–F299
45. Staub, O., Dho, S., Henry, P., Correa, J., Ishikawa, T., McGlade, J., and
Rotin, D. (1996) WW domains of Nedd4 bind to the proline-rich PY mo-
tifs in the epithelial Na
 channel deleted in Liddle’s syndrome. EMBO J.
15, 2371–2380
46. He, Y. F., Bao, H.M., Xiao, X. F., Zuo, S., Du, R. Y., Tang, S.W., Yang, P. Y.,
and Chen, X. (2009) Biotin tagging coupled with amino acid-coded mass
tagging for efficient and precise screening of interaction proteome in
mammalian cells. Proteomics 9, 5414–5424
47. Liang, S., Yu, Y., Yang, P., Gu, S., Xue, Y., and Chen, X. (2009) Analysis of
the protein complex associated with 14-3-3 by a deuterated-leucine la-
beling quantitative proteomics strategy. J. Chromatogr. B Analyt. Technol.
Biomed. Life Sci. 877, 627–634
48. Angrand, P. O., Segura, I., Völkel, P., Ghidelli, S., Terry, R., Brajenovic, M.,
Vintersten, K., Klein, R., Superti-Furga, G., Drewes, G., Kuster, B., Bouw-
meester, T., and Acker-Palmer, A. (2006) Transgenic mouse proteomics
identifies new 14-3-3-associated proteins involved in cytoskeletal rear-
rangements and cell signaling.Mol. Cell Proteomics 5, 2211–2227
49. Lehoux, S., Abe, Ji., Florian, J. A., and Berk, B. C. (2001) 14-3-3 Binding to
Na
/H
 exchanger isoform-1 is associated with serum-dependent acti-
vation of Na
/H
 exchange. J. Biol. Chem. 276, 15794–15800
14-3-3 Regulation of AQP2
2484 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 5•JANUARY 29, 2016
 at D
EF Consortium
 - U
niv Library of Southern D
enm
ark on June 9, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Nanna MacAulay, Soeren K. Moestrup, Vivek Bhalla and Robert A. Fenton
Hanne B. Moeller, Joachim Slengerik-Hansen, Takwa Aroankins, Mette Assentoft,
ζ and -θRegulation of the Water Channel Aquaporin-2 via 14-3-3
doi: 10.1074/jbc.M115.691121 originally published online December 8, 2015
2016, 291:2469-2484.J. Biol. Chem. 
  
 10.1074/jbc.M115.691121Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/291/5/2469.full.html#ref-list-1
This article cites 49 references, 30 of which can be accessed free at
 at D
EF Consortium
 - U
niv Library of Southern D
enm
ark on June 9, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
